With reference to its Letter dated 4th August 2026 vide which it has submitted the unaudited Financial Results (Standalone and Consolidated) of the Company for the First Quarter ended 30th June 2026, Sudeep Pharma has submitted copies of the Extract of unaudited Financial Results of the Company for the First Quarter ended 30th June 2026, on Consolidated basis, published in Business Standard, English language newspaper, Ahmedabad and Vadodara Samachar and Gujarat Samachar, Regional language newspapers at Vadodara, Gujarat on 5th August, 2026. The above information is also available on the Company’s website at https://www.sudeeppharma.com/.
The above information is a part of company’s filings submitted to BSE.
| Company Name | CMP |
|---|---|
| Sun Pharma. Inds. | 1949.00 |
| Dr. Reddys Labs. | 1172.00 |
| Cipla | 1472.00 |
| Lupin | 2360.00 |
| Zydus Lifesciences | 1115.20 |
| View more.. | |
Start Research-backed Investing ...Now. Subscribe to Sapphire
MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.
To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.
MoneyWorks4Me ensures this through: